Bioadaptives (BDPT) Debt to Equity (2019 - 2025)
Historic Debt to Equity for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to -$0.66.
- Bioadaptives' Debt to Equity fell 1589.64% to -$0.66 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.66, marking a year-over-year decrease of 1589.64%. This contributed to the annual value of -$0.72 for FY2024, which is 2115.14% down from last year.
- Per Bioadaptives' latest filing, its Debt to Equity stood at -$0.66 for Q3 2025, which was down 1589.64% from -$0.76 recorded in Q2 2025.
- Over the past 5 years, Bioadaptives' Debt to Equity peaked at -$0.47 during Q4 2022, and registered a low of -$0.76 during Q2 2025.
- Over the past 5 years, Bioadaptives' median Debt to Equity value was -$0.59 (recorded in 2023), while the average stood at -$0.59.
- In the last 5 years, Bioadaptives' Debt to Equity tumbled by 2537198.85% in 2021 and then skyrocketed by 2584.62% in 2022.
- Bioadaptives' Debt to Equity (Quarter) stood at -$0.51 in 2021, then grew by 7.15% to -$0.47 in 2022, then decreased by 25.5% to -$0.59 in 2023, then decreased by 21.15% to -$0.72 in 2024, then grew by 8.23% to -$0.66 in 2025.
- Its Debt to Equity was -$0.66 in Q3 2025, compared to -$0.76 in Q2 2025 and -$0.63 in Q1 2025.